Drug discovery is a high-risk, high-cost endeavor, with over 90% of candidates failing in clinical development. A significant proportion of these ...

The pharmaceutical supply chain and device development have become intricately linked. Harmonizing formulation development ...

Innovation drives speed in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions integrate advanced ...

The release of the U.S. National Security Strategy landed like a grenade in Brussels, underscoring the depth of ideological ...

Viking Therapeutics advances oral and injectable VK2735 for obesity with strong cash, pipeline depth, and key 2026 catalysts.

The Trump administration released its much-anticipated National Security Strategy this week. CFR convened six of its experts ...

Regulatory pressures in the European Union are rapidly reshaping the landscape for cosmetics and fragrance companies. New ...

Atossa Therapeutics, Inc. (Nasdaq: ATOS) is a clinical-stage biopharmaceutical company developing novel therapies in oncology, including (Z)-endoxifen, to improve outcomes for patients across the ...

Rentschler Biopharma, a global CDMO, and Coriolis Pharma, a global contract research and development organization, have ...

Goldman Sachs Industrials and Materials Conference 2025 December 3, 2025 1:30 PM ESTCompany ParticipantsPierre Brondeau - CEO ...

CEO Qiming He details how Newsun’s China-rooted, globally deployed innovation model is redefining biosolutions and ...